Carfilez Injection 30 mg/vial contains Carfilzomib, a proteasome inhibitor used in the treatment of multiple myeloma. It is an advanced anticancer medicine that works by blocking proteasome activity in cancer cells, leading to accumulation of abnormal proteins and triggering cancer cell death. Carfilzomib is typically used in patients with relapsed or refractory multiple myeloma as part of combination therapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Carfilzomib 30 mg per vial
• Dosage Form: Sterile powder for intravenous injection
• Route: Intravenous infusion only

Mechanism of Action

Carfilzomib selectively and irreversibly inhibits the 20S proteasome in cancer cells. This prevents the breakdown of damaged or unwanted proteins, causing cellular stress and apoptosis (programmed cell death). It is particularly effective against rapidly dividing malignant plasma cells in multiple myeloma.

Indications

Carfilez Injection is indicated for:

• Relapsed or refractory multiple myeloma
• Multiple myeloma in patients who have received prior therapy
• Combination therapy with other anticancer agents as prescribed by an oncologist

Dosage and Administration

• Must be administered under strict supervision of an oncologist
• Given as intravenous infusion according to treatment protocol
• Dose is calculated based on body surface area and clinical condition
• Treatment is given in cycles with careful monitoring
• Pre- and post-infusion hydration may be required

Precautions

• Risk of cardiovascular complications (monitor heart function)
• Use with caution in patients with heart disease or hypertension
• Kidney and liver function should be monitored regularly
• May cause tumor lysis syndrome in high tumor burden cases
• Not recommended during pregnancy unless clearly necessary

Side Effects

Common side effects include:

• Fatigue
• Nausea and vomiting
• Diarrhea
• Fever and chills
• Shortness of breath

Serious side effects:

• Heart failure or cardiac toxicity
• Hypertension
• Severe infections
• Kidney dysfunction
• Infusion-related reactions

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store below 25°C in a cool, dry place
• Protect from light
• Reconstituted solution should be used as directed
• Keep out of reach of children

Conclusion

Carfilez Injection 30 mg/vial (Carfilzomib) is a potent proteasome inhibitor used in the treatment of multiple myeloma. It works by disrupting cancer cell protein regulation, leading to cell death. Due to its strong effects and potential risks, it should be administered only under specialist oncological supervision.